Hyperkinetic movement disorders associated with HIV and other viral infections

Handbook of Clinical Neurology

Volumn 100, Issue , 2011, Pages 323-334

  Carroll, Elizabeth ^a   Sanchez ramos, Juan ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOOK; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERKINESIA; VIROLOGY; VIRUS INFECTION;

HIV INFECTIONS; HUMANS; HYPERKINESIS; VIRUS DISEASES;

EID: 79954562207     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52014-2.00025-2     Document Type: Book

References (92)

1. Abbruzzese G., Rizzo F., Dall'Agata D., et al. Generalized dystonia with bilateral striatal computed-tomographic lucencies in a patient with human immunodeficiency virus infection. Eur Neurol 1990, 30:271-273.
2. ARNM Acute epidemic encephalitis (lethargic encephalitis). Report of the Papers and Discussion at the Meeting of the Association, New York City December 28th and 29th, 1920 1921, Association for Research in Nervous and Mental Diseases, New York. P. Bailey (Ed.).
3. Aylward E.H., Henderer J.D., McArthur J.C., et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 1993, 43:2099-2104.
4. Barre-Sinoussi F., Chermann J.C., Rey F., et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220:868-871.
5. Berger J.R., Kumar M., Kumar A., et al. Cerebrospinal fluid dopamine in HIV-1 infection. Aids 1994, 8:67-71.
6. Borucki M.J., Matzke D.S., Pollard R.B. Tremor induced by trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988, 109:77-78.
7. Bosanko C.M., Gilroy J., Wang A.M., et al. West Nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch Neurol 2003, 60:1448-1452.
8. Brew B.J. HIV Neurology 2001, Oxford University Press, New York.
9. Burton G.F., Keele B.F., Estes J.D., et al. Follicular dendritic cell contributions to HIV pathogenesis. Semin Immunol 2002, 14:275-284.
10. Cardoso F. HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs 2002, 16:663-668.
11. CDC Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 1999, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta.
12. CDC Prion Diseases Department of Health and Human Services. Available online at:. http://www.cdc.gov/ncidod/dvrd/prions/.
13. Collie D.A., Summers D.M., Sellar R.J., et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 2003, 24:1560-1569.
14. Dale R.C., Church A.J., Surtees R.A.H., et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004, 127:21-33.
15. Dal Pan G.J., McArthur J.H., Aylward E., et al. Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology 1992, 42:2125-2130.
16. De Tiege X., Rozenberg F., Des Portes V., et al. Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology 2003, 61:241-243.
17. De Tiege X., De Laet C., Mazoin N., et al. Postinfectious immune-mediated encephalitis after pediatric herpes simplex encephalitis. Brain Dev 2005, 27:304-307.
18. Deuschl G., Krack P., Lauk M., et al. Clinical neurophysiology of tremor. J Clin Neurophysiol 1996, 13:110-121.
19. Factor S.A., Podskalny G.D., Barron K.D. Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report. J Neurol Sci 1994, 127:114-120.
20. Forno L.S. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996, 55:259-272.
21. Fulbright R.K., Hoffmann C., Lee H., et al. MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol 2008, 29:1638-1643.
22. Gallo B.V., Shulman L.M., Weiner W.J., et al. HIV encephalitis presenting with severe generalized chorea. Neurology 1996, 46:1163-1165.
23. Gallo R.C., Salahuddin S.Z., Popovic M., et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984, 224:500-503.
24. Garretto N.S., Bueri J.A., Kremenchutzky M., et al. [Hemichorea associated with cerebral toxoplasmosis and AIDS]. Arq Neuropsiquiatr 1995, 53:118-122.
25. Grandas F. Ballism. Parkinson's Disease and Movement Disorders 2002, Lippincott Williams & Wilkins, Philadelphia. J. Jankovic, E. Tolosa (Eds.).
26. Hollander H., Golden J., Mendelson T., et al. Extrapyramidal symptoms in AIDS patients given low-dose metoclopramide or chlorpromazine. Lancet 1985, 2:1186.
27. Jean C.M., Honarmand S., Louie J.K., et al. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 2007, 13:1918-1920.
28. Jeha L.E., Sila C.A., Lederman R.J., et al. West Nile virus infection: a new acute paralytic illness. Neurology 2003, 61:55-59.
29. Kalita J., Misra U.K. The substantia nigra is also involved in Japanese encephalitis. AJNR Am J Neuroradiol 2000, 21:1978-1980.
30. Khosla J.S., Edelman M.J., Kennedy N., et al. West Nile Virus presenting as opsoclonus-myoclonus and cerebellar ataxia. Neurology 2005, 64:1095.
31. Kompoliti K., Goetz C.G., Gajdusek D.C., et al. Movement disorders in Kuru. Mov Disord 1999, 14:800-804.
32. Krauss J.K., Pohle T., Borremans J.J. Hemichorea and hemiballism associated with contralateral hemiparesis and ipsilateral basal ganglia lesions. Mov Disord 1999, 14:497-501.
33. Kullnat M.W., Morse R.P. Choreoathetosis after herpes simplex encephalitis with basal ganglia involvement on MRI. Pediatrics 2008, 121:e1003-e1007.
34. Kumar S., Misra U.K., Kalita J., et al. MRI in Japanese encephalitis. Neuroradiology 1997, 39:180-184.
35. Lee M.S., Marsden C.D. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord 1994, 9:493-507.
36. Lopez O.L., Smith G., Meltzer C.C., et al. Dopamine systems in human immunodeficiency virus-associated dementia. Neuropsychiatry Neuropsychol Behav Neurol 1999, 12:184-192.
37. Lowe J., Lennox G., Leigh P.N. Disorders of movement and system degenerations. Greenfield's Neuropathology 1997, Arnold, London. D. Graham, P. Lantos (Eds.).
38. Lubetzki C., Vidailhet M., Jedynak C.P., et al. [Propriospinal myoclonus in a HIV seropositive patient]. Rev Neurol (Paris) 1994, 150:70-72.
39. Maggi P., de Mari M., De Blasi R., et al. Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis. Mov Disord 1996, 11:434-436.
40. Maher J., Choudhri S., Halliday W., et al. AIDS dementia complex with generalized myoclonus. Mov Disord 1997, 12:593-597.
41. Maltete D., Guyant-Marechal L., Mihout B., et al. Movement disorders and Creutzfeldt-Jakob disease: a review. Parkinsonism Relat Disord 2006, 12:65-71.
42. Marschitz I., Rodl S., Gruber-Sedlmayr U., et al. Severe chorea with positive anti-basal ganglia antibodies after herpesencephalitis. J Neurol Neurosurg Psychiatry 2007, 78:105-107.
43. Martino D., Giovannoni G. Antibasal ganglia antibodies and their relevance to movement disorders. Curr Opin Neurol 2004, 17:425-432.
44. Mattos J.P., Rosso A.L., Correa R.B., et al. Movement disorders in 28 HIV-infected patients. Arq Neuropsiquiatr 2002, 60:525-530.
45. McCall S., Henry J.M., Reid A.H., et al. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. J Neuropathol Exp Neurol 2001, 60:696-704.
46. Mirsattari S.M., Berry M.E., Holden J.K., et al. Paroxysmal dyskinesias in patients with HIV infection. Neurology 1999, 52:109-114.
47. Misra U.K., Kalita J. Movement disorders in Japanese encephalitis. J Neurol 1997, 244:299-303.
48. Nash D., Mostashari F., Fine A., et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001, 344:1807-1814.
49. Nath A., Jankovic J., Pettigrew L.C. Movement disorders and AIDS. Neurology 1987, 37:37-41.
50. Nath A., Hobson D.E., Russell A. Movement disorders with cerebral toxoplasmosis and AIDS. Mov Disord 1993, 8:107-112.
51. Navia B.A., Cho E.S., Petito C.K., et al. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986, 19:525-535.
52. Navia B.A., Jordan B.D., Price R.W. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986, 19:517-524.
53. Navia B.A., Petito C.K., Gold J.W., et al. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 1986, 19:224-238.
54. Nitrini R., Areza-Fegyveres R., Martins V.R., et al. [Asymmetric cortical high signal on diffusion weighted-MRI in a case of Creutzfeldt-Jakob disease]. Arq Neuropsiquiatr 2005, 63:519-522.
55. Noel S., Guillaume M.P., Telerman-Toppet N., et al. Movement disorders due to cerebral Toxoplasma gondii infection in patients with the acquired immunodeficiency syndrome (AIDS). Acta Neurol Belg 1992, 92:148-156.
56. O'Leary D.R., Marfin A.A., Montgomery S.P., et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 2004, 4:61-70.
57. O'Leary D.R., Kuhn S., Kniss K.L., et al. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics 2006, 117:e537-e545.
58. Pardo J., Marcos A., Bhathal H., et al. Chorea as a form of presentation of human immunodeficiency virus-associated dementia complex. Neurology 1998, 50:568-569.
59. Piatak M., Saag M.S., Yang L.C., et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993, 259:1749-1754.
60. Piccolo I., Causarano R., Sterzi R., et al. Chorea in patients with AIDS. Acta Neurol Scand 1999, 100:332-336.
61. Piccolo I., Sterzi R., Thiella G., et al. Sporadic choreas: analysis of a general hospital series. Eur Neurol 1999, 41:143-149.
62. Popovic M., Sarngadharan M.G., Read E., et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984, 224:497-500.
63. Reyes M.G., Faraldi F., Senseng C.S., et al. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1991, 82:39-44.
64. Rottenberg D.A., Moeller J.R., Strother S.C., et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987, 22:700-706.
65. Royce R.A., Sena A., Cates W., et al. Sexual transmission of HIV. N Engl J Med 1997, 336:1072-1078.
66. Sakaie K.E., Gonzalez R.G. Imaging of Neuroaids. NeuroAids 1999, 2.
67. Sanchez-Ramos J.R., Factor S.A., Weiner W.J., et al. Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis. Mov Disord 1989, 4:266-273.
68. Sardar A.M., Czudek C., Reynolds G.P. Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 1996, 7:910-912.
69. Schupbach M., Popovic RV., Gilden M.A., et al. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science 1984, 224:503-505.
70. Sejvar J.J., Haddad M.B., Tierney B.C., et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003, 290:511-515.
71. Simpson D.M., Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994, 121:769-785.
72. Solomon T. Flavivirus encephalitis. N Engl J Med 2004, 351:370-378.
73. Solomon T. New vaccines for Japanese encephalitis. Lancet Neurol 2008, 7:116-118.
74. Solomon T., Vaughn D.W. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 2002, 267:171-194.
75. Solomon T., Dung N.M., Kneen R., et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 2002, 125:1084-1093.
76. Solomon T., Dung N.M., Wills B., et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 2003, 361:821-826.
77. Solomon T., Ooi M.H., Beasley D.W., et al. West Nile encephalitis. BMJ 2003, 326:865-869.
78. Sporer B., Linke R., Seelos K., et al. HIV-induced chorea: evidence for basal ganglia dysregulation by SPECT. J Neurol 2005, 252:356-358.
79. Tilney F., Howe H.S. Epidemic Encephalitis 1920, Paul B, Hoeber, New York.
80. Tolge C.F., Factor S.A. Focal dystonia secondary to cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome. Mov Disord 1991, 6:69-72.
81. Trocello J.M., Blanchet A., Bourdain F., et al. [Resolution of choreic movements associated with HIV encephalitis with anti-retroviral therapy]. Rev Neurol (Paris) 2006, 162:89-91.
82. Tse W., Cersosimo M.G., Gracies J.M., et al. Movement disorders and AIDS: a review. Parkinsonism Relat Disord 2004, 10:323-334.
83. Tyler K.L. West Nile virus infection in the United States. Arch Neurol 2004, 61:1190-1195.
84. van Der Kleij F.G., de Vries P.A., Stassen P.M., et al. Acute dystonia due to metoclopramide: increased risk in AIDS. Arch Intern Med 2002, 162:358-359.
85. Van Gerpen J.A. Tremor caused by trimethoprim-sulfamethoxazole in a patient with AIDS. Neurology 1997, 48:537-538.
86. Vilensky J.A., Goetz C.G., Gilman S. Movement disorders associated with encephalitis lethargica: a video compilation. Mov Disord 2006, 21:1-8.
87. Weiner W.J., Lang A.E. Movement Disorders. A Comprehensive Survey 1989, Future Press, Mount Kisco, NY.
88. Wenserski F., von Giesen H.J., Wittsack H.J., et al. Human immunodeficiency virus 1-associated minor motor disorders: perfusion-weighted MR imaging and HMR spectroscopy. Radiology 2003, 228:185-192.
89. WHO Revision of the Surveillance Case Definition for Variant Creutzfeldt-Jakob Disease (vCJD) 2002, Available online at:. http://www.who.int/emc.
90. Will R.G., Ironside J.W., Zeidler M., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996, 347:921-925.
91. Will R.G., Zeidler M., Stewart G.E., et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000, 47:575-582.
92. Zeidler M., Green A. Advances in diagnosing Creutzfeldt-Jakob disease with MRI and CSF 14-3-3 protein analysis. Neurology 2004, 63:410-411.